Further studies in rat models of CDD revealed that WLD improves symptoms by enhancing urinary d-xylose excretion rates and increasing serum levels of gastrin (GAS) and motilin (MTL) [16]. Here, GAST is linked to craniodiaphyseal dysplasia.